Younger, female, and BME doctors are more likely to have revalidation deferredBMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1925 (Published 02 May 2018) Cite this as: BMJ 2018;361:k1925
- Gareth Iacobucci
- The BMJ
Deferral of revalidation is likelier among younger doctors, women, and doctors from black and minority ethnic backgrounds, a major impact study has found.1
The three year review by the UK Medical Revalidation Evaluation Collaboration (UMbRELLA) found that the General Medical Council’s objective to bring most doctors into a governed system of medical revalidation had largely been achieved since it was introduced in 2012. But it noted that engagement had generally been less straightforward for doctors working for more than one organisation.
Responsible officers (the individuals within designated bodies, such as NHS employers, who have overall responsibility for revalidation) can make one of three recommendations to the GMC after a five year revalidation period: approval, deferral, or non-engagement with the revalidation process. Deferral can be recommended if there is not enough evidence to recommend a doctor’s revalidation, if a doctor is under …